# 68Ga-PMD22 PET/CT Examination Targeting CLDN18.2

> **NCT05937919** · EARLY_PHASE1 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Gastrointestinal Cancer

## Interventions

- **DRUG:** Intravenous injection of 68Ga-PMD22

## Key facts

- **NCT ID:** NCT05937919
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-28
- **Primary completion:** 2023-08-31
- **Final completion:** 2023-08-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2023-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05937919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05937919, "68Ga-PMD22 PET/CT Examination Targeting CLDN18.2". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05937919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*